Construction and protective efficacy of a novel Streptococcus pneumoniae fusion protein vaccine NanAT1-TufT1-PlyD4

During the past decades, with the implementation of pneumococcal polysaccharide vaccine (PPV) and pneumococcal conjugate vaccines (PCVs), a dramatic reduction in vaccine type diseases and transmissions has occurred. However, it is necessary to develop a less expensive, serotype-independent pneumococ...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yali, Miao, Chenglin, Chen, Wen, Shang, Wenling, Qi, Qianqian, Zhou, Wei, Wang, Xia, Li, Yingying, Yan, Ziyi, Jiang, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659761/
https://www.ncbi.nlm.nih.gov/pubmed/36389808
http://dx.doi.org/10.3389/fimmu.2022.1043293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659761/
https://www.ncbi.nlm.nih.gov/pubmed/36389808
http://dx.doi.org/10.3389/fimmu.2022.1043293

Ejemplares similares